Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Early-Stage Non-Small Cell Lung Cancer

NCT07412327 is registered in ClinicalTrials.gov with Guangzhou Concord Cancer Center as lead sponsor.

NCT NCT07412327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07412327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Early-Stage Non-Small Cell Lung Cancer
Lead sponsor
Guangzhou Concord Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
February 24, 2026
Completion date
July 1, 2029
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage lung cancer, lung cancer